STOCKWATCH: Suits in suites look to deal better hands in 2014
This article was originally published in Scrip
Executive Summary
As the great and the good of the healthcare world (as well as the rest of us) descend on San Francisco for the annual JP Morgan Healthcare conference from 13-16 January, the focus of attention may not be on the companies' formal presentations. In 2014, the most interesting meetings will be the ones you are not invited to, those that are held in the hotel suites within four or five blocks of Union Square.
You may also be interested in...
Stock Watch: Risk And The Pharmaceutical Discount Rate
In contrast to the SEC’s view that public companies’ regulatory filings give investors all the information needed to make an investment decision, the discount rate used to value a company may not reflect all its risks.
Stock Watch: Pharma Businesses That Leave Consumer Behind
Healthcare conglomerates that divorce consumer, animal health and even generics businesses from their pure-play branded pharmaceutical groups could leave a less diversified and riskier sector in uncertain times. But the advantages are apparent.
Stock Watch: Acadia And Amylyx Trial Failures Were No Shock
The overused phrase ‘pipeline in a product’ translates to ‘disappointment in a product’ when the number of indications in the pipeline contracts towards zero.